Nanox Imaging is trading 5% down at $0.89 amid broad risk-off trading.

  • The stock declined from its August 17 close of $0.93; the Nasdaq is down 1.33% and the S&P 500 is down 0.64%.
  • Investor concerns remain elevated ahead of expected second-quarter results, following preliminary revenue of approximately $4.0–$4.1 million and cash of about $31.4 million as of June 30.
  • Nanox announced a UK HealthOST reseller agreement on August 18; no investor reaction was disclosed.